COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis – California and New York, May-November 2021COVID-19 예방 접종 상태 및 이전 COVID-19 진단에 따른 COVID-19 사례 및 입원 - 캘리포니아 및 뉴욕, 2021년 5월-11월Article Published on 2022-01-282022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] 변종, [키워드] accounted analyzed booster dose booster doses both group both groups cause changed Cohort cohorts completion COVID-19 COVID-19 case COVID-19 diagnosis COVID-19 incidence COVID-19 vaccination death deaths declined delta variant diagnoses Diagnosis diagnosis of COVID-19 Duration of infection eligible Epidemic Epidemiology highest Hospitalization hospitalizations immune evasion Immunity immunization Immunologic Infection infection with SARS-CoV-2 isolates laboratory-confirmed magnitude New New York occurred omicron outcome predominant Prevent previous diagnosis PROTECT public health recommendation Reinfection SARS-COV-2 infection SARS-CoV-2 infections sequenced status study period Surveillance the SARS-CoV-2 three groups vaccination vaccine dose vaccine doses Vaccine-induced immunity variants virus with COVID-19 [DOI] 10.15585/mmwr.mm7104e1 PMC 바로가기 [Article Type] Article
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence – 25 U.S. Jurisdictions, April 4-December 25, 2021델타 및 오미크론 변이형 출현 기간 동안 추가 접종 여부와 관계없이 백신 접종을 하지 않은 성인 및 완전히 예방 접종을 받은 성인의 COVID-19 발병률 및 사망률 - 25 미국 관할 구역, 2021년 4월 4일-12월 25일Article Published on 2022-01-282022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] 변종, [키워드] accounted averaged B.1.1.529 B.1.617.2 booster dose booster doses cause CDC COVID-19 COVID-19 case COVID-19 illness COVID-19 vaccinations COVID-19 vaccine death death rate death rates declined Delta dose emergence groups highest Hospitalization Immunocompromised incidence rate Infection Lineage omicron Omicron variant Period Rate receipt risk SARS-CoV-2 sequenced serious COVID-19 the United State The United States United States vaccination Vaccination Status Vaccinations Vaccine Vaccine-induced immunity variant variant of SARS-CoV-2 virus was recorded with COVID-19 [DOI] 10.15585/mmwr.mm7104e2 PMC 바로가기 [Article Type] Article
Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19낮은 수준의 과립구 골수 유래 억제 세포는 중증 COVID-19 환자의 추적 관찰에서 생존의 좋은 지표가 될 수 있습니다Observational Study Published on 2022-01-282022-09-12 Journal: Frontiers in Immunology [Category] 임상, 진단, [키워드] activated acute respiratory syndrome association cause Cell cells circulating contribute coronavirus coronavirus disease COVID-19 COVID-19 patients death develop died discharge discharged disease Endpoint Evolution examined Follow-up Good Granulocytic ICU immunological Immunosuppression Increased Infection inhibitory intensive care Level lymphocyte Lymphocytes MDSCs Mortality OX40 Pathogenesis Patient patients Patients with cancer PD-1 question raised SARS-CoV-2 SARS-CoV2 severe COVID-19 suppressor Tregs two group [DOI] 10.3389/fimmu.2021.801410 PMC 바로가기 [Article Type] Observational Study
Effects of the COVID-19 pandemic on sexual functioning and activity: a systematic review and meta-analysisResearch Published on 2022-01-282022-10-28 Journal: BMC Public Health [Category] COVID-19, SARS, [키워드] activities affected affecting cause China CINAHL Cochrane Library Community confidence interval correlated COVID-19 COVID-19 pandemic difference dimension dysfunction Effect effective evaluate the effect evaluated Evidence Factor female participants Frequency function global pandemic greater heterogeneous identify impacted increase in index individuals majority male participants men Meta-analysis meta-analytical new virus participant Psychological PsycINFO public health measure reduce reduced reduction in reported researcher restriction Result SARS-CoV-2 Sex sexual Sexual functioning and activity SMD Spread statistically significant Stress supplementary material systematic review and meta-analysis viral outbreak was used Web of Science were assessed women Wuhan [DOI] 10.1186/s12889-021-12390-4 PMC 바로가기 [Article Type] Research
Potential Antiviral Action of AlkaloidsReview Published on 2022-01-282022-10-30 Journal: Molecules [Category] COVID-19, [키워드] acting Action alkaloid alkaloids Antiviral antiviral activity antiviral agent antiviral drug antiviral therapeutics biological activities cause Characteristics Concentration DNA DNA and RNA Effect effective Efficacy Efficiency effort Evidence highlight humans identify Infection inhibition inhibitory concentration molecular morbidity and mortality natural products outbreak Pandemics plants Potential protein synthesis public health emergency Research RNA Safe specificity targets Treatment Vaccine Viral diseases viral entry viral replication virus viruses [DOI] 10.3390/molecules27030903 PMC 바로가기 [Article Type] Review
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19Research Article Published on 2022-01-272022-10-28 Journal: PLoS ONE [Category] COVID-19, SARS, [키워드] Admission age analyzed Asymptomatic biochemical cause clinical endpoint Clinical outcome clinical setting Control control patients cumulative death develop duration of symptom Effect Efficacy evaluate exposure to hospital ICU admission improvement in vitro In-hospital inflammatory parameters Laboratory laboratory parameter less lung infiltrate lung infiltrates lymphocyte monocyte multicenter Multivariate analysis no difference Non-COVID-19 outcome Patient patients hospitalized Protective pulmonary infiltrate receiving Result Retrospective study SARS-COV-2 infection serious COVID-19 severity Sex shown survival Treatment two groups Valproic acid were recorded with COVID-19 worsening [DOI] 10.1371/journal.pone.0262777 PMC 바로가기 [Article Type] Research Article
Duration of Protection against Mild and Severe Disease by Covid-19 VaccinesCovid-19 백신에 의한 경증 및 중증 질병에 대한 보호 기간Article Published on 2022-01-272022-09-11 Journal: The New England Journal of Medicine [Category] 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age Alpha B.1.1.7 B.1.617.2 BNT162b2 BNT162b2 vaccine BNT162b2 vaccines Case-control cause ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1-S clinical risk clinically condition coronavirus coronavirus disease Coronavirus disease 2019 death delta variant dose Duration effective Effectiveness England greater healthy Hospitalization less medical condition Older peaked protection real-world data receipt SARS-CoV-2 second dose severe acute respiratory syndrome Coronavirus severe disease shown status symptomatic COVID-19 the vaccine United Kingdom vaccination Vaccine vaccine dose variant variants virus [DOI] 10.1056/NEJMoa2115481 PMC 바로가기 [Article Type] Article
Sexual and Reproductive Health during the COVID-19 Pandemic: Results from a Cross-Sectional Online Survey in GermanyArticle Published on 2022-01-272022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] accumulated Administered Adults cause change changes in country COVID-19 COVID-19 pandemic cross-sectional decrease Effect Evidence Germany Health Impact increase in increases in Intervention maintain Online pandemic problem producing Psychological stress Quantitative reproductive resources Result Satisfaction sexual sexual and reproductive health Sexual behaviour survey [DOI] 10.3390/ijerph19031428 PMC 바로가기 [Article Type] Article
Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort다기관 영국 코호트에서 기능적 말단 보체 경로 결핍의 임상 결과 및 기본 유전적 원인Multicenter Study Published on 2022-01-272022-09-10 Journal: Journal of Clinical Immunology [Category] 변종, [키워드] affected analysed antigenic Asian Asymptomatic booster cause CFH CFI clinical Clinical course Clinical outcome Cohort complement Complement pathway Concentration conditions Consumption COVID-19 deficiencies deficiency develop diagnosed died Factor H Factor I family history family member genetic etiology Genetic testing Genetic variation genetics Infection infections intensive care investigated laboratory data lack management median age Meningococcal infection one patient pathogenic pathway Patient patients prophylactic antibiotics provided Regulatory Result Screening secondary to septicaemia serotype serum Seven suffered supplementary material terminal Terminal complement pathway the patient treated Two patient two patients Vaccine variants [DOI] 10.1007/s10875-022-01213-9 PMC 바로가기 [Article Type] Multicenter Study
An Artificial Intelligence Approach for Expurgating Edible and Non-Edible Items먹을 수 있는 것과 먹을 수 없는 것을 없애기 위한 인공 지능 접근 방식Public Health Published on 2022-01-272022-09-11 Journal: Frontiers in Public Health [Category] SARS, 치료기술, [키워드] Affect artificial artificial intelligence auto can not cause Complete detect Device distribution dose everything exposure to food safety food sanitization fruits germicidal Health hygiene intelligence item leads limit machine learning for health mineral nutrition pandemic of COVID-19 pathogen Pathogens Protein Proteins smart device smart sanitization smart system ultraviolet C UVC virus viruses [DOI] 10.3389/fpubh.2021.825468 PMC 바로가기 [Article Type] Public Health